Shoman Kasbekar


Shoman is part of the investment team at Foresite Capital, and is focused on opportunities in life sciences and healthcare technology.

Shoman came to Foresite from Synthego, a life sciences company building automated platforms for CRISPR genome editing. At Synthego he managed strategy and business development across genome editing technologies, discovery platforms, and therapeutics. Prior to Synthego, Shoman held roles in strategy and finance at DaVita, a healthcare company serving over 200,000 patients with kidney disease. At DaVita, Shoman was a part of the Redwoods Leadership program, and received a DaVita Star award for exceptional achievement. Shoman has also held roles at Sharecare, a leading digital health company, and at the Vanderbilt Technology Transfer & Commercialization center. In addition to his work with Foresite Capital, Shoman is a member of the strategic alliances team at the Rare Genomics Institute, a non-profit dedicated to helping rare disease patients and their families find a cure. Shoman received his B.E. in Biomedical Engineering from Vanderbilt University.


  • Experience in corporate strategy, business development, and product across the healthcare value chain, from life science technology to healthcare delivery.
  • Active in the nonprofit sector as a leader at the Rare Genomics Institute, an organization helping rare disease patients find a cure.
  • Writer on biotech and healthcare, with tens of thousands of views.